Bionano Genomics, Inc. (BNGO) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$28.5M

Net Income/Loss (FY2025)

-$26.4M

Total Assets (FY2025)

$73.6M

Total Equity (FY2025)

$44.4M

Cash Flows from Operating Activities (FY2025)

-$16.3M

Source: Bionano Genomics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.